U.S. to allow states to distribute Gilead's remdesivir to fight COVID-19
Reuters India -

The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc's remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker's global donation.

Read this story at , , , ,


Related Articles